These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8503063)

  • 1. Herpes revisited. Still a cause of concern.
    Catotti DN; Clarke P; Catoe KE
    Sex Transm Dis; 1993; 20(2):77-80. PubMed ID: 8503063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychosocial impact of human papillomavirus infection: implications for health care providers.
    Clarke P; Ebel C; Catotti DN; Stewart S
    Int J STD AIDS; 1996; 7(3):197-200. PubMed ID: 8799782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common questions about herpes: analysis of chat-room transcripts.
    Gilbert LK; Omisore F
    Herpes; 2009 Jan; 15(3):57-61. PubMed ID: 19306604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where do people go for treatment of sexually transmitted diseases?
    Brackbill RM; Sternberg MR; Fishbein M
    Fam Plann Perspect; 1999; 31(1):10-5. PubMed ID: 10029927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral form of acyclovir approved.
    FDA Drug Bull; 1985 Apr; 15(1):3-4. PubMed ID: 4039694
    [No Abstract]   [Full Text] [Related]  

  • 8. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.
    Rahi JS; Manaras I; Tuomainen H; Hundt GL
    Pediatrics; 2004 Oct; 114(4):e477-82. PubMed ID: 15466074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of acyclovir in the treatment of recurring herpes labialis, genitalis and acute herpes zoster.
    Peralta S; Ribisi La Spina AM; Pirrotta P; Collura D; Formica P; Tinnirello D; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1117-8. PubMed ID: 16312797
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychosocial issues in genital herpes management.
    Green J
    Herpes; 2004 Dec; 11(3):60-2. PubMed ID: 15960901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing and treating genital herpes.
    Chard S
    Nurs Times; 1998 Nov 18-24; 94(46):58-62. PubMed ID: 9923385
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment to prevent recurrent genital herpes.
    Martinez V; Caumes E; Chosidow O
    Curr Opin Infect Dis; 2008 Feb; 21(1):42-8. PubMed ID: 18192785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological and psychosexual implications of herpes simplex virus infections.
    Mindel A
    Scand J Infect Dis Suppl; 1996; 100():27-32. PubMed ID: 9163020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral acyclovir: a pill to easy to swallow?
    Barriere SL
    Clin Pharm; 1984; 3(6):655. PubMed ID: 6542477
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The British Columbia Positive Women's Survey: a detailed profile of 110 HIV-infected women.
    Kirkham CM; Lobb DJ
    CMAJ; 1998 Feb; 158(3):317-23. PubMed ID: 9484255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.